Find Clinical Trials | Cedars-Sinai

352 results found

Lung

Amgen, 20230153, Ph 2, randomized, open-label, NSCLC, AMG193

Primary Objective: To characterize safety and efficacy of 2 dose levels of AMG 193 by investigator.

Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Melanoma

Pfizer Inc, C5901001, Ph 1, Open-Label, Multi-Center, Melanoma, Solid Tumor, PF-08046031

Primary -To characterize the safety and tolerability profile of PF-08046031 in participants with advanced melanomas and select solid tumors (Parts 1, 2, 3) -To identify the MTD or MAD of PF-08046031 (Part 1) -To identify a recommended dose for ...